Last checked at 2 Jul 2021 14:55
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | J.P. Morgan Securities LLC |
Company dealt in | AON plc |
Class of relevant security to which the dealings being disclosed relate (Note 2) | US$0.01 ordinary shares |
Date of dealing | 01 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities | 6,800,892 3.01 | 2,162,774 0.96 | ||||
(2) Derivatives (other than options) | 1,845,637 0.82 | 82,228 0.04 | ||||
(3) Options and agreements to purchase/sell | 166,900 0.07 | 376,500 0.17 | ||||
Total | 8,813,429 3.90 | 2,621,502 1.17 | ||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale |
Number of relevant securities |
Price per unit (USD)
(Note 5) |
Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase Purchase
Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale Sale |
100 1,100 1,217 700 1 2 1 300 7 315 11,957 35,855 3 118 53 400
1 2 19 100 100 35 2 3 12 2 2 100 14 303 3 3 19 500 5 300 1 732 43 1,100 11 6 200 1 38 416 5 8 1 202 1 12,323 26,494 35,855 200 967 1 3 3 33 14 307 1 1,649 200 200 2 300 700 565 1,001 193 600 70 64 94 370 |
239.3100 USD 239.2855 USD 239.1269 USD 239.0871 USD 239.0450 USD 239.0100 USD 238.9550 USD 238.9183 USD 238.9050 USD 238.8000 USD 238.6800 USD 238.6500 USD 238.5750 USD 238.5564 USD 238.5456 USD 238.4675 USD
239.4900 USD 239.3600 USD 239.2453 USD 239.2000 USD 239.1700 USD 239.1183 USD 239.1050 USD 239.0767 USD 239.0633 USD 239.0200 USD 239.0100 USD 239.0000 USD 238.9764 USD 238.9700 USD 238.9667 USD 238.9467 USD 238.9458 USD 238.9440 USD 238.9340 USD 238.9183 USD 238.9000 USD 238.8902 USD 238.8788 USD 238.8618 USD 238.8591 USD 238.8567 USD 238.8300 USD 238.8200 USD 238.8032 USD 238.8000 USD 238.7920 USD 238.7738 USD 238.7700 USD 238.7300 USD 238.7200 USD 238.6800 USD 238.6639 USD 238.6500 USD 238.6300 USD 238.6260 USD 238.6200 USD 238.5950 USD 238.5750 USD 238.5550 USD 238.5400 USD 238.5323 USD 238.5300 USD 238.5268 USD 238.5000 USD 238.4900 USD 238.4700 USD 238.4200 USD 238.4100 USD 238.4081 USD 238.4003 USD 238.4000 USD 238.3650 USD 238.3494 USD 238.3300 USD 238.3222 USD 238.2941 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (USD) (Note 5) |
|
Equity Swap | Decrease Short
Increase Long | 3
300 | 238.5950 USD
238.9183 USD |
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price (USD) | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) (USD) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other
person relating to the voting rights of any relevant securities under any option referred to on this form or relating
to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred
to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) Yes
Date of disclosure | 02 July 2021 |
Contact name | Alwyn Basch |
Telephone number | 0207 742 7407 |
If a connected EFM, name of offeree/offeror with which connected | N/A |
If a connected EFM, state nature of connection (Note 10) | N/A |
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, e.g. call option | Written, or purchased | Number of relevant securities to which the option or derivative relates | Exercise price (Note 2) (USD) | Type, e.g. American, European etc. | Expiry date |
Call Option Call Option Call Option Call Option Put Option Call Option Put Option Call Option Put Option Call Option Call Option Call Option Call Option Put Option | Written Written Written Written Written Written Written Purchased Written Purchased Purchased Purchased Purchased Written | 46,200 71,700 77,400 104,700 600 3,100 44,000 13,800 8,200 72,000 54,200 26,600 300 20,600 | 270.00 270.00 270.00 270.00 240.00 270.00 230.00 240.00 230.00 260.00 260.00 260.00 240.00 250.00 | American American American American American American American American American American American American American American | 17/12/2021 17/12/2021 17/12/2021 17/12/2021 15/10/2021 17/12/2021 15/10/2021 16/07/2021 16/07/2021 17/12/2021 15/10/2021 16/07/2021 15/10/2021 17/12/2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.